General Information of the Compound
Compound ID |
CP0168326
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-N'-[3-fluoro-4-[5-methyl-6-(3-morpholin-4-ylpropoxy)pyrrolo[2,1-f][1,2,4]triazin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C31H32F2N6O5
|
||||||||||||||||||
Molecular Weight |
606.63
|
||||||||||||||||||
Canonical SMILES |
Cc1c(OCCCN2CCOCC2)cn2ncnc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)c12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C31H32F2N6O5/c1-20-26(43-14-2-11-38-12-15-42-16-13-38)18-39-27(20)28(34-19-35-39)44-25-8-7-23(17-24(25)33)37-30(41)31(9-10-31)29(40)36-22-5-3-21(32)4-6-22/h3-8,17-19H,2,9-16H2,1H3,(H,36,40)(H,37,41)
Show/Hide
|
||||||||||||||||||
InChIKey |
OEZOMMSDHODKOJ-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01201, Hepatocyte growth factor receptor
Cell Viability or Cytotoxicity Assay
Cell Line ID | Cell Line Name | Cell Line Organism | |
CL000246 | NCI-H292 | Homo sapiens (Human) | 1 |
1 |
IC50 >= 50 nM
|
TI
LI
LO
TS
|
|
---|---|---|---|
CL000504 | EBC-1 | Homo sapiens (Human) | 1 |
1 |
IC50 = 4.3 nM
|
TI
LI
LO
TS
|